LGND
Ligand Pharmaceuticals Inc
$288.05-0.78 (-0.27%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
26 of 243 tradesExecutives investing their own money
🤖AI Insight
Latest Insider Transactions
Showing 10 of 243 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-09-03 | Reardon Andrew | CLO | Sale | 2,115 | $286.36 | $605,649 | N/A | N/A |
| 2026-09-08 | 2026-09-03 | Reardon Andrew | CLO | Sale | 1,800 | $285.17 | $513,301 | N/A | N/A |
| 2026-09-08 | 2026-09-03 | Reardon Andrew | CLO | Sale | 400 | $288.98 | $115,592 | N/A | N/A |
| 2026-09-08 | 2026-09-03 | Reardon Andrew | CLO | Sale | 385 | $287.53 | $110,697 | N/A | N/A |
| 2026-09-08 | 2026-09-03 | Reardon Andrew | CLO | Sale | 300 | $283.99 | $85,196 | N/A | N/A |
| 2026-08-14 | 2026-08-12 | Espinoza Octavio | CFO | Exercise Conversion | 7,171 | $57.22 | $410,325 | N/A | N/A |
| 2026-08-14 | 2026-08-12 | Espinoza Octavio | CFO | Exercise Conversion | 2,869 | $55.75 | $159,947 | N/A | N/A |
| 2026-08-14 | 2026-08-12 | Haas Jason | Director | Exercise Conversion | 6,138 | $51.56 | $316,475 | N/A | N/A |
| 2026-08-14 | 2026-08-12 | Haas Jason | Director | Exercise Conversion | 6,138 | $51.56 | $316,475 | N/A | N/A |
| 2026-08-14 | 2026-08-12 | Haas Jason | Director | Sale | 7,138 | $292.81 | $2,090,064 | N/A | N/A |
LGND
CFO
Exercise Conversion
$410.3K
Espinoza Octavio7,171 shares @ $57.22
Filed 2026-08-14Trade 2026-08-12
LGND
CFO
Exercise Conversion
$159.9K
Espinoza Octavio2,869 shares @ $55.75
Filed 2026-08-14Trade 2026-08-12
LGND
Director
Exercise Conversion
$316.5K
Haas Jason6,138 shares @ $51.56
Filed 2026-08-14Trade 2026-08-12
LGND
Director
Exercise Conversion
$316.5K
Haas Jason6,138 shares @ $51.56
Filed 2026-08-14Trade 2026-08-12
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.